Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-21 Sale | 2024-03-25 9:46 pm | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 834,459 | $40.86 | $34,099,583 | 2,793,987 (Indirect) | View |
| 2024-01-30 Purchase | 2024-02-01 5:58 pm | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 161,290 | $31 | $4,999,990 | 3,628,446 (Indirect) | View |
| 2023-09-19 Purchase | 2023-09-21 5:10 pm | RayzeBio Inc. | RYZB | Katabi Maha Director | 472,222 | $18 | $8,499,996 | 1,209,764 (Indirect) | View |
| 2022-11-28 Sale | 2023-02-27 9:15 pm | CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner | 6,000 | $14.32 | $85,920 | 0 (Indirect Direct) | View |
| 2023-02-06 Purchase | 2023-02-08 6:29 pm | Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner | 285,714 | $7 | $1,999,998 | 3,467,156 (Direct) | View |
| 2022-08-11 Purchase | 2022-08-15 3:46 pm | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner | 500,000 | $30 | $15,000,000 | 6,073,949 (Indirect) | View |
| 2022-02-10 Purchase | 2022-02-14 6:17 pm | Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha 10% Owner | 266,666 | $15 | $3,999,990 | 3,181,442 (Direct) | View |
| 2022-01-11 Purchase | 2022-01-13 4:38 pm | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner | 325,000 | $16 | $5,200,000 | 5,573,949 (Indirect) | View |
| 2021-07-02 Purchase | 2021-07-06 4:27 pm | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 357,142 | $14 | $4,999,988 | 3,761,153 (Indirect Direct) | View |
| 2021-05-18 Purchase | 2021-05-18 8:17 pm | Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner | 727,272 | $11 | $7,999,992 | 2,914,776 (Indirect) | View |
| 2021-02-09 Purchase | 2021-02-09 6:04 pm | Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner | 450,000 | $20 | $9,000,000 | 2,754,437 (Direct) | View |
| 2020-07-28 Purchase | 2020-07-28 6:08 pm | Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 437,500 | $16 | $7,000,000 | 2,028,308 (Direct) | View |
| 2020-06-30 Purchase | 2020-07-01 9:36 pm | Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 58,823 | $17 | $999,991 | 1,515,073 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-05 Option Award | 2024-06-07 6:00 pm | N/A 2034-06-04 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 4:13 pm | N/A 2034-05-14 | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:47 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Katabi Maha Director | 18,235 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:47 pm | N/A N/A | RayzeBio Inc. | RYZB | Katabi Maha Director | 1,209,764 | $62.5 | 0 (Indirect) | View |
| 2024-01-02 Option Award | 2024-01-04 6:00 pm | N/A 2034-01-01 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 3,519 | $13.49 | 3,519 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-17 6:37 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Katabi Maha Director | 18,235 | $0 | 18,235 (Direct) | View |
| 2023-09-19 Conversion | 2023-09-21 5:10 pm | N/A N/A | RayzeBio Inc. | RYZB | Katabi Maha Director | 1,947,306 | $0 | 1,209,764 (Indirect) | View |
Ownership | 2023-09-14 7:27 pm | N/A N/A | RayzeBio Inc. | RYZB | Katabi Maha Director | 0 | $0 | 1,947,306 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-08 6:00 pm | N/A 2033-06-05 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:14 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-24 Disposition | 2023-02-27 9:15 pm | N/A N/A | CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner | 19,608 | $0 | 0 (Direct) | View |
| 2023-02-24 Equity Swap | 2023-02-27 9:15 pm | N/A N/A | CinCor Pharma Inc. | CINC | HEALY JAMES Katabi Maha Sofinnova Management X L.P. Sofinnova Management X-A L.L.C. Sofinnova Venture Partners X L.P. Director 10% Owner | 6,083,752 | $0 | 0 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:00 pm | N/A 2033-01-02 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 2,627 | $18.08 | 2,627 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 5:00 pm | N/A 2032-06-20 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:11 pm | N/A 2032-05-23 | Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner | 9,925 | $0 | 9,925 (Direct) | View |
| 2022-01-11 Conversion | 2022-01-13 4:38 pm | N/A N/A | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha 10% Owner | 23,095,377 | $0 | 5,573,949 (Indirect) | View |
Ownership | 2022-01-06 8:54 pm | N/A N/A | CinCor Pharma Inc. | CINC | Sofinnova Venture Partners X L.P. Katabi Maha Sofinnova Management X L.L.C. 10% Owner | 0 | $0 | 5,248,949 (Indirect) | View |
| 2022-01-03 Option Award | 2022-01-05 5:15 pm | N/A 2032-01-02 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 7,240 | $6.56 | 7,240 (Direct) | View |
| 2021-07-02 Conversion | 2021-07-06 4:27 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 13,966,782 | $0 | 3,761,153 (Indirect) | View |
| 2021-07-01 Option Award | 2021-07-06 4:27 pm | N/A 2031-06-30 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 2,467 | $11.15 | 3,761,153 (Direct) | View |
| 2021-06-29 Option Award | 2021-07-01 6:34 pm | N/A 2031-06-28 | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 25,000 | $0 | 13,073,286 (Direct) | View |
| 2021-02-01 Option Award | 2021-07-01 6:34 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 9,246,403 | $1.893 | 13,073,286 (Indirect) | View |
Ownership | 2021-06-29 7:42 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner | 0 | $0 | 3,401,544 (Indirect) | View |
| 2021-05-18 Conversion | 2021-05-18 8:17 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner | 2,187,504 | $0 | 2,914,776 (Indirect) | View |
| 2021-05-13 Option Award | 2021-05-17 8:40 pm | N/A 2031-05-12 | Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner | 9,925 | $0 | 9,925 (Direct) | View |
Ownership | 2021-05-13 7:21 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner | 0 | $0 | 2,187,504 (Indirect) | View |
| 2021-02-09 Conversion | 2021-02-09 6:04 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner | 2,304,437 | $0 | 2,754,437 (Direct) | View |
Ownership | 2021-02-04 8:59 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner | 0 | $0 | 2,304,437 (Direct) | View |
| 2020-07-28 Conversion | 2020-07-28 6:08 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 13,478,920 | $0 | 2,028,308 (Direct) | View |
Ownership | 2020-07-23 9:31 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL Katabi Maha 10% Owner | 0 | $0 | 1,590,808 (Direct) | View |
| 2020-06-30 Conversion | 2020-07-01 9:36 pm | N/A N/A | Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 32,143,835 | $0 | 1,515,073 (Direct) | View |